Story perspectives

Australian Innovator's mRNA Vaccine Shrinks Dog's Cancer Tumor

3/18/2026

Summary

Story summary

Paul Conyngham, an Australian tech entrepreneur, developed a personalized mRNA cancer vaccine for his dog Rosie, using ChatGPT and DNA sequencing, with the UNSW Ramaciotti Centre for Genomics.
Ethics-approval challenges arose, but the vaccine reached the University of Queensland’s lab.
Rosie received her first shot in December.
Rosie’s tumor has shrunk.
Conyngham believes the treatment has improved Rosie’s quality of life, which researchers hope will spur advances in cancer treatments.

1 of 1

Story summary

Paul Conyngham, an Australian tech entrepreneur, developed a personalized mRNA cancer vaccine for his dog Rosie, using ChatGPT and DNA sequencing, with the UNSW Ramaciotti Centre for Genomics.
Ethics-approval challenges arose, but the vaccine reached the University of Queensland’s lab.
Rosie received her first shot in December.
Rosie’s tumor has shrunk.
Conyngham believes the treatment has improved Rosie’s quality of life, which researchers hope will spur advances in cancer treatments.